News | December 11, 2025
Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Roche says its new assay “resolves this challenge by delivering accurate and specific results
The formulation is backed by over 80 clinical trials and 200 scientific publications
Marks first international filing for Evofem’s single-dose oral treatment
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
An estimated 21 million American women experience BV
The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Subscribe To Our Newsletter & Stay Updated
